Galderma

Palatin Technologies, Inc., based in Cranbury, NJ, specializes in discovering and developing innovative therapeutics aimed at treating inflammatory and autoimmune conditions by harnessing the healing power of the melanocortin system. The company's focus is on creating effective solutions that balance efficacy, safety, and tolerability, enhancing patient care in areas with unmet medical needs. By leveraging their extensive knowledge of the melanocortin system, Palatin aims to resolve harmful inflammation, providing a novel therapeutic approach that allows affected tissues time to heal. Their current pipeline prioritizes the development of treatments for ocular conditions, showcasing their commitment to addressing chronic health issues. Generated from the website